DCM VI, L.P. - 28 Oct 2021 Form 4 Insider Report for Augmedix, Inc.

Reporting relationship: Director, 10%+ Owner
Issuer ticker: N/A
Reported as of: 28 Oct 2021
Net transaction value: +$1,750,000
SEC form: 4
Accepted by SEC: 01 Nov 2021, 20:25:41 UTC
Source filing: View source filing
Reporting owner signature: DCM VI, L.P. By /s/ Matthew Bonner, Chief Operating Officer & Legal Partner

Key filing fact

DCM VI, L.P. filed Form 4 for Augmedix, Inc. on 01 Nov 2021.

Key facts

This page summarizes DCM VI, L.P.'s Form 4 filing for Augmedix, Inc..
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Nov 2021, 20:25.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: +$1,750,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AUGX transaction

Common Stock

Purchase

Transaction value: $1,750,000
Shares: +437,500
Change %: +12%
Price: $4.00
Shares after: 4,168,918
Date: 28 Oct 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These securities are held of record by DCM VI, L.P. ("DCM VI"). Jason Krikorian, a member of the Issuer's board of directors, is a general partner at DCM, which is an affiliate of DCM VI. As a result, DCM VI is a director by deputization for Section 16 purposes.